YD Bio (YDES) Cash & Equivalents (2024 - 2026)
YD Bio's (YDES) quarterly Cash & Equivalents came in at $2.7 million in Q2 2026, up 466.96% year-over-year from $469520.0 in Q2 2025, and down 55.69% quarter-over-quarter from $6.0 million in Q4 2025.
Powered by 
Analysis
YD Bio (YDES) Cash & Equivalents (2024 - 2026) Analysis & Trends
YD Bio (YDES) has reported Cash & Equivalents for 3 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 466.96% year-over-year to $2.7 million in Q2 2026; TTM through Jun 2026 was $2.7 million, a 466.96% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, up 91.8% from the prior year.
- Cash & Equivalents was $2.7 million for Q2 2026 at YD Bio, down from $6.0 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $6.0 million in Q4 2025 and troughed at $469520.0 in Q2 2025.
- A 3-year average of $3.1 million and a median of $2.9 million in 2024 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents surged 91.8% in 2025 and soared 466.96% in 2026, its largest moves.
- Over 3 years, Cash & Equivalents stood at $3.1 million in 2024, then jumped by 91.8% to $6.0 million in 2025, then slumped by 55.69% to $2.7 million in 2026.
- The last three Cash & Equivalents figures came in at $2.7 million (Q2 2026), $6.0 million (Q4 2025), and $469520.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 13.99 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 3.18 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 6.14 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 2.46 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 1.72 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 3.58 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 1.71 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 1.29 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 1.25 Bn |
| 10 | YD Bio | 225.82 Mn | 223.16 Mn | - | 2.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.66 Mn |
| Dec 31, 2025 | 6.01 Mn |
| Jun 30, 2025 | 469,520.00 |
| Dec 31, 2024 | 3.13 Mn |
API Access
YD Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=YDES&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "YDES", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=YDES&period=max&api_key=YOUR_API_KEY");
const data = await res.json();